1. Home
  2. BARK vs NTHI Comparison

BARK vs NTHI Comparison

Compare BARK & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BARK Inc.

BARK

BARK Inc.

HOLD

Current Price

$10.67

Market Cap

92.7M

ML Signal

HOLD

Logo NeOnc Technologies Holdings Inc.

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$4.65

Market Cap

109.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BARK
NTHI
Founded
2011
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
92.7M
109.5M
IPO Year
2020
2023

Fundamental Metrics

Financial Performance
Metric
BARK
NTHI
Price
$10.67
$4.65
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$37.50
$15.00
AVG Volume (30 Days)
51.4K
200.7K
Earning Date
06-03-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$394,843,000.00
$39,990.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.43
N/A
P/E Ratio
$126.25
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.50
$3.01
52 Week High
$11.32
$12.99

Technical Indicators

Market Signals
Indicator
BARK
NTHI
Relative Strength Index (RSI) 58.62 58.50
Support Level $8.49 $4.18
Resistance Level $10.94 $5.78
Average True Range (ATR) 0.63 0.63
MACD 0.06 0.22
Stochastic Oscillator 75.84 60.97

Price Performance

Historical Comparison
BARK
NTHI

About BARK BARK Inc.

BARK Inc is a vertically integrated, omnichannel brand serving dogs across two key categories: toys & accessories and consumables. It serves dogs nationwide with monthly subscription services, BarkBox and Super Chewer; e-commerce experience on BarkShop.com; custom collections via its retail partner network, including Target and Amazon; wellness products that meet dogs' needs with BARK Bright; and a personalized meal delivery service for dogs BARK Eats. The company's reportable segments are; Direct to Consumer (D2C), and Commerce. The majority of its revenue is generated from the Direct to Consumer segment which derives revenue from the sale of toys & accessories and consumables through BarkBox, Super Chewer, and the company's consumables website.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: